Skip to content

Sunday, February 28, 2021

Latest:

Resilience Through COVID-19: Dr. Dharani Narendra
Black History Month Spotlight: Interview with Dr. Darius Dawson
Healthy Habits: A DOC-umentary Series – Dr. Christie Ballantyne
Black History Month Spotlight: Interview with Dr. Kathryn Jones
What you should know about at-home genetic testing

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

Akt pathway

Targeting MAPK4 emerges as a promising therapy for prostate cancer

February 23, 2021February 23, 2021 Ana Rodríguez 0 Comments Akt pathway, androgen receptor, cancer therapy, castration-resistant prostate cancer, MAPK4, Prostate Cancer, Research

Inhibiting MAPK4 simultaneously inactivated both androgen receptor and AKT and stopped cancer growth in animal models.

CD44s, not CD44v, contributes to cancer survival

July 25, 2017May 11, 2018 Ana Rodríguez 0 Comments Akt pathway, alternative splicing, cancer survival, CD44, EGFR signaling

Cells may stray away from their normal function in a number of ways. For example, it’s been known for some time that in a number

From the Labs Image of the Month

From the Labs features an award-winning image of immunofluorescent HeLa cells. Image credit: K. Engevik/Hyser lab.

Archives

Archives

Search

©1998 - 2020 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951